Search research articles
Contact Us
Filters
Showing results (141-150 of 230) with videos related to
Page
of 23
Sort By:
Cancer
|
September 8, 2011
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
Ana M Molina, Darren R Feldman, Martin H Voss, et al.
Investigational New Drugs
|
August 17, 2010
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
Ana M Molina, Darren R Feldman, Michelle S Ginsberg, et al.
Annals of Surgical Oncology
|
September 19, 2013
Impact of margin assessment method on positive margin rate and total volume excised
Tracy-Ann Moo, Lydia Choi, Candice Culpepper, et al.
Plos One
|
December 16, 2014
Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival
Gary Tozbikian, Edi Brogi, Kyuichi Kadota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with <i>PIK3CA</i>-Mutated HER2-Positive Metastatic Breast Cancer
Komal Jhaveri, Joshua Z Drago, Payal Deepak Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Distress in older patients with cancer
Arti Hurria, Daneng Li, Kurt Hansen, et al.
The Pediatric Infectious Disease Journal
|
August 28, 2007
Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients
Anjali Chelliah, Kateri H Heydon, Theoklis E Zaoutis, et al.
Annals of Surgical Oncology
|
June 15, 2007
Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast
Andrea V Barrio, Bradly D Clark, Jessica I Goldberg, et al.
Clinical Breast Cancer
|
July 7, 2011
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
Ayca Gucalp, Joseph A Sparano, James Caravelli, et al.
BMC Urology
|
July 4, 2020
Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
Yasser Ged, Ruby Gupta, Cihan Duzgol, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 230) with videos related to
Sort By:
Page
of 23
Cancer
|
September 8, 2011
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
Ana M Molina, Darren R Feldman, Martin H Voss, et al.
Investigational New Drugs
|
August 17, 2010
Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
Ana M Molina, Darren R Feldman, Michelle S Ginsberg, et al.
Annals of Surgical Oncology
|
September 19, 2013
Impact of margin assessment method on positive margin rate and total volume excised
Tracy-Ann Moo, Lydia Choi, Candice Culpepper, et al.
Plos One
|
December 16, 2014
Mesothelin expression in triple negative breast carcinomas correlates significantly with basal-like phenotype, distant metastases and decreased survival
Gary Tozbikian, Edi Brogi, Kyuichi Kadota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with <i>PIK3CA</i>-Mutated HER2-Positive Metastatic Breast Cancer
Komal Jhaveri, Joshua Z Drago, Payal Deepak Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Distress in older patients with cancer
Arti Hurria, Daneng Li, Kurt Hansen, et al.
The Pediatric Infectious Disease Journal
|
August 28, 2007
Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients
Anjali Chelliah, Kateri H Heydon, Theoklis E Zaoutis, et al.
Annals of Surgical Oncology
|
June 15, 2007
Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast
Andrea V Barrio, Bradly D Clark, Jessica I Goldberg, et al.
Clinical Breast Cancer
|
July 7, 2011
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer
Ayca Gucalp, Joseph A Sparano, James Caravelli, et al.
BMC Urology
|
July 4, 2020
Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
Yasser Ged, Ruby Gupta, Cihan Duzgol, et al.
Page
of 23